Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients; analysis of the UK Medical Research Council AML 10 Trial.

Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients; analysis of the UK Medical Research Council AML 10 Trial.

The increasing success of intensive consolidation chemotherapy (CCT) as an alternative to bone marrow transplant (BMT) in acute myeloid leukaemia (AML) necessitates comparison of the impact on quality of life (QoL) of these two treatment modalities. Most QoL studies following BMT involve small patie...

Full description

Bibliographic Details
Main Authors:	Watson, M, Buck, G, Wheatley, K, Homewood, JR, Goldstone, A, Rees, J, Burnett, A
Format:	Journal article
Language:	English
Published:	2004

Similar Items

The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial.
by: Burnett, A, et al.
Published: (2002)

A simple, robust and highly predictive prognostic index for the determination of risk directed therapy in acute myeloid leukaemia (AML) derived from the United Kingdom medical research council (MRC) AML10 trial.
by: Wheatley, K, et al.
Published: (1995)

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.
by: Grimwade, D, et al.
Published: (1998)

Severe adverse impact on sexual functioning and fertility of bone marrow transplantation, either allogeneic or autologous, compared with consolidation chemotherapy alone: analysis of the MRC AML 10 trial.
by: Watson, M, et al.
Published: (1999)

Outcome for children with relapsed acute myeloid leukaemia following initial therapy in the Medical Research Council (MRC) AML 10 trial. MRC Childhood Leukaemia Working Party.
by: Webb, D, et al.
Published: (1999)

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial.
by: Grimwade, D, et al.
Published: (2001)

EVI1 expression in acute myeloid leukaemia.
by: Langabeer, SE, et al.
Published: (2001)

Impact of diagnostic cytogenetics on outcome in AML: Analysis of 1,613 patients entered into the UK MRC AML 10 trial.
by: Grimwade, D, et al.
Published: (1996)

The addition of the mTORr inhibitor, Everolimus, to consolidation therapy in acute myeloid leukaemia: experience from the UK NCRI AML17 trial
by: Burnett, AK, et al.
Published: (2018)

Transformation of myelodysplastic syndrome (MDS) to acute myeloid leukaemia (AML)
by: Goh, Chermaine Yu Zhen
Published: (2021)

A comparison of FLAG-Ida and daunorubicin combined with clofarabine in high-risk acute myeloid leukaemia: data from the UK NCRI AML17 Trial
by: Burnett, A, et al.
Published: (2018)

Acute Myeloid Leukaemia (AML) Presenting as a Bilateral Pleural Effusion
by: Ranjan Agrawal
Published: (2013-01-01)

Chemotherapy of acute myeloid leukaemia in adults: Medical Research Council.
by: Cuckle, H, et al.
Published: (1979)

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials.
by: Kottaridis, P, et al.
Published: (2001)

P503: A RANDOMISED TRIAL OF MOLECULAR MONITORING VERSUS STANDARD CLINICAL CARE IN YOUNGER ADULTS WITH ACUTE MYELOID LEUKAEMIA: RESULTS FROM THE UK NCRI AML17 AND AML19 STUDIES
by: Nicola Potter, et al.
Published: (2023-08-01)

The role of AML secretome and bone marrow microenvironment in establishment and maintenance of leukaemia initiating cells
by: Ren, X
Published: (2023)

Bone marrow transplantation in AML, and socioeconomic class: a UK population-based cohort study
by: Das-Gupta Emma, et al.
Published: (2010-09-01)

UK Medical Research Council randomised, multicentre trial of interferon-alpha n1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response. The UK Medical Research Council's Working Parties for Therapeutic Trials in Adult Leukaemia.
by: Allan, N, et al.
Published: (1995)

Cytogenetic profile of acute myeloid leukaemia (AML) patients in Singapore General Hospital (SGH)
by: Ho, Charmaine Jia Yi
Published: (2024)

The epidemiology, treatment patterns, healthcare utilizations and costs of Acute Myeloid Leukaemia (AML) in Taiwan.
by: Huai-Hsuan Huang, et al.
Published: (2022-01-01)

The importance of diagnostic cytogenetics in older patients with AML: Analysis of 922 patients entered into the MRC AML 11 trial.
by: Grimwade, D, et al.
Published: (1999)

An unusual case of intrapulmonary granulocytic sarcoma presenting as interstitial pneumonitis following allogeneic bone marrow transplantation for acute myeloid leukaemia and responding to donor lymphocyte infusion.
by: Kottaridis, P, et al.
Published: (1999)

Del(9q) AML: Clinical, cytological and cytogenetic characteristics and prognostic implications for patients entering the MRC AML trials.
by: Peniket, A, et al.
Published: (1999)

P580: THE USE OF LEUKAEMIA Q-FUSION GENE SCREENING ASSAY (Q30) IN THE DIAGNOSTIC EVALUATION OF ACUTE MYELOID LEUKAEMIA (AML)
by: S. Tayabali, et al.
Published: (2022-06-01)

Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experience. Medical Research Council Working Party on Childhood Leukaemia.
by: Wheeler, K, et al.
Published: (1998)

Acute Myeloid Leukaemia Drives Metabolic Changes in the Bone Marrow Niche
by: Rebecca S. Maynard, et al.
Published: (2022-06-01)

Del (9q) AML: clinical and cytological characteristics and prognostic implications.
by: Peniket, A, et al.
Published: (2005)

Surface-modified vacuole-based daunorubicin delivery system for acute myeloid leukaemia (AML) and their selective therapeutics
by: Wooil Choi, et al.
Published: (2022-12-01)

Bone marrow transplantation.
by: Vyas, P, et al.
Published: (1990)

Concurrence of chronic lymphocytic leukaemia/small lymphocytic lymphoma and acute myeloid leukaemia in a bone marrow biopsy
by: Stefano Licci
Published: (2020-10-01)

Improved outcome of acute myeloid leukaemia in Down's syndrome.
by: Craze, J, et al.
Published: (1999)

Relationships between age at diagnosis, clinical features and outcome of therapy in children treated in the Medical Research Council trials for acute myeloid leukemia AML 10 and 12.
by: Webb, D, et al.
Published: (2000)

Relationships between age at diagnosis, clinical features, and outcome of therapy in children treated in the Medical Research Council AML 10 and 12 trials for acute myeloid leukemia.
by: Webb, D, et al.
Published: (2001)

Intensive chemotherapy and bone marrow transplantation for infant lymphoblastic leukaemia.
by: Chessells, J, et al.
Published: (1997)

Consensus on BCR-ABL1 reporting in chronic myeloid leukaemia in the UK
by: Cross, N, et al.
Published: (2018)

Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia.
by: Chessells, J, et al.
Published: (1995)

Allogeneic Stem Cell Transplantation in Refractory Acute Myeloid Leukaemia
by: Roberto Bono, et al.
Published: (2024-04-01)

Intensification of treatment for adults with acute lymphoblastic leukaemia: results of U.K. Medical Research Council randomized trial UKALL XA. Medical Research Council Working Party on Leukaemia in Adults.
by: Durrant, I, et al.
Published: (1997)

Preliminary results of the UK Medical Research Council trial in chronic lymphocytic leukaemia - CLL3
by: Catovsky, D, et al.
Published: (1998)

Psychotropic Drug Use in Acute Myeloid Leukaemia (AML) and Myelodysplastic Syndrome (MDS): A Danish Nationwide Matched Cohort Study of 2404 AML and 1307 MDS Patients
by: Jensen O, et al.
Published: (2022-02-01)